Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564051 · ClinicalTrials.gov registry record
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 29
- Enrollment target
NCT06564051: Clinical Trial study, sponsored by Mayo Clinic.
NCT06564051 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564051 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.
Primary Outcome
Blood samples collected in conjunction with routine clinical blood draws will be tested for MBL and compared with post-therapy samples and with control patients (without hepatitis C).
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2025-12-03 |
Why NCT06564051 stopped before completion
NCT06564051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06564051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06564051 about?
NCT06564051 is a clinical study titled "Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C". This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.
What is the current status of trial NCT06564051?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2017-11-14. Estimated completion is 2025-12-03.
What interventions are being tested in trial NCT06564051?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06564051?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI